Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2015

Open Access 01-12-2015 | Research article

Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates

Published in: BMC Musculoskeletal Disorders | Issue 1/2015

Login to get access

Abstract

Background

Death certificates can be used to assess disease prevalence and incidence; however, rheumatoid arthritis (RA) often remains unreported in death certificates. We sought to determine to what extent RA is underreported and what demographic and clinical characteristics could predict mention of RA in the death certificate.

Methods

We recruited 1328 patients with RA from private, public and military rheumatology practices and followed them prospectively for yearly evaluations. A rheumatologist assessed clinical characteristics of RA and comorbidities at each evaluation. Deaths were identified through family members, other physicians, obituaries and public death databases. All were confirmed with state-issued death certificates. Patients with and without RA in death certificate were compared using bivariate and multivariate analyses.

Results

By December 2013, 326 deaths had occurred. We received and reviewed death certificates for all confirmed deaths, of which 58 (17.7 %) mentioned RA on the death certificate. Bivariate analysis revealed that younger age, a greater number of deformities, higher Sharp score and lower socioeconomic status were each associated with recording RA. Multivariable analyses revealed that comorbidity [OR (95 % CI) = 0.84 (0.73, 0.97); P = 0.022] was inversely associated with listing RA on the death certificate, while the number of deformities [OR (95 % CI) = 1.04 (1.00, 1.07); P = 0.033] and a certified physician’s signature on the death certificate [OR (95 % CI) = 4.79 (1.35, 16.9); P = 0.015] increased likelihood of reporting RA.

Conclusion

In this cohort, RA was not listed in over 80 % of death certificates. Younger patients with fewer comorbidities and more joint deformities were more likely to have RA reported.

Discussion

RA is often not included in death certificates. The findings of this study suggest that older patients may have a greater number of comorbidities, thus decreasing the likelihood that RA be included when completing the death certificate.
Literature
1.
go back to reference Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum. 2008;58:15–25.CrossRefPubMed Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum. 2008;58:15–25.CrossRefPubMed
2.
go back to reference Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26:S35–61.PubMed Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26:S35–61.PubMed
3.
go back to reference Gabriel SE, Crowson CS, O’Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol. 1999;26:2529.PubMed Gabriel SE, Crowson CS, O’Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol. 1999;26:2529.PubMed
5.
6.
go back to reference Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate: eleven-year follow-up of an epidemiological study. Scand J Rheumatol. 1981;10(4):301–6.CrossRefPubMed Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate: eleven-year follow-up of an epidemiological study. Scand J Rheumatol. 1981;10(4):301–6.CrossRefPubMed
7.
go back to reference Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337–47.CrossRefPubMed Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337–47.CrossRefPubMed
8.
go back to reference Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol. 2006;2:99–106.CrossRefPubMed Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol. 2006;2:99–106.CrossRefPubMed
9.
go back to reference Ruyssen-Witrand A, Fautrel B, Saraux A, Le Loët X, Pham T. Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine. 2011;78:23–30.CrossRefPubMed Ruyssen-Witrand A, Fautrel B, Saraux A, Le Loët X, Pham T. Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine. 2011;78:23–30.CrossRefPubMed
10.
go back to reference Ethgen O, de Lemos EF, Bruyere O, Reginster JY. What do we know about the safety of corticosteroids in rheumatoid arthritis? Curr Med Res Opin. 2013;29:1147–60.CrossRefPubMed Ethgen O, de Lemos EF, Bruyere O, Reginster JY. What do we know about the safety of corticosteroids in rheumatoid arthritis? Curr Med Res Opin. 2013;29:1147–60.CrossRefPubMed
11.
go back to reference Rincón I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2014;66:264–72.CrossRef Rincón I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2014;66:264–72.CrossRef
12.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
13.
go back to reference Escalante A, del Rincón I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum. 1999;42:1712–21.CrossRefPubMed Escalante A, del Rincón I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum. 1999;42:1712–21.CrossRefPubMed
14.
go back to reference Escalante A, del Rincon I. The disablement process in rheumatoid arthritis. Arthritis Rheum. 2002;47:333–42.CrossRefPubMed Escalante A, del Rincon I. The disablement process in rheumatoid arthritis. Arthritis Rheum. 2002;47:333–42.CrossRefPubMed
15.
go back to reference Escalante A, del Rincón I, Mulrow CD. Symptoms of depression and psychological distress among Hispanics with rheumatoid arthritis. Arthritis Care Res. 2000;13(3):156–67.CrossRefPubMed Escalante A, del Rincón I, Mulrow CD. Symptoms of depression and psychological distress among Hispanics with rheumatoid arthritis. Arthritis Care Res. 2000;13(3):156–67.CrossRefPubMed
16.
go back to reference Nam CB, Powers MG. The socioeconomic approach to status measurement with a guide to occupational and socioeconomic status scores. Houston: Cap & Gown Press; 1983. Nam CB, Powers MG. The socioeconomic approach to status measurement with a guide to occupational and socioeconomic status scores. Houston: Cap & Gown Press; 1983.
17.
go back to reference Orces CH, Del Rincón I, Abel MP, Escalante A. The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis. Arthritis Rheum. 2002;47:67–72.CrossRefPubMed Orces CH, Del Rincón I, Abel MP, Escalante A. The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis. Arthritis Rheum. 2002;47:67–72.CrossRefPubMed
18.
go back to reference del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA- DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum. 2002;46:1480–8.CrossRefPubMed del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA- DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum. 2002;46:1480–8.CrossRefPubMed
19.
go back to reference Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum. 1985;28:1326–35.CrossRefPubMed Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum. 1985;28:1326–35.CrossRefPubMed
20.
go back to reference Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria for rheumatoid arthritis. JAMA. 1949;140:659–66.CrossRef Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria for rheumatoid arthritis. JAMA. 1949;140:659–66.CrossRef
21.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
22.
go back to reference Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34:73–84.CrossRefPubMed Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34:73–84.CrossRefPubMed
23.
go back to reference Navarro Cano G, del Rincón I, Pogosian S, Roldán JF, Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum. 2003;48:2425–33.CrossRefPubMed Navarro Cano G, del Rincón I, Pogosian S, Roldán JF, Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum. 2003;48:2425–33.CrossRefPubMed
24.
go back to reference Calvo-Alen J, Alarcón GS, Campbell R, Fernandez M, Reveille JD, Cooper GS. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology. 2005;44:1186–9.CrossRefPubMed Calvo-Alen J, Alarcón GS, Campbell R, Fernandez M, Reveille JD, Cooper GS. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology. 2005;44:1186–9.CrossRefPubMed
25.
go back to reference Nowels D. Completing and signing the death certificate. Am Fam Physician. 2004;70:1813–8.PubMed Nowels D. Completing and signing the death certificate. Am Fam Physician. 2004;70:1813–8.PubMed
26.
go back to reference Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O’Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54–8. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O’Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54–8.
27.
go back to reference Lakkireddy DR, Gowda MS, Murray CW, Basarakodu KR, Vacek JL. Death certificate completion: how well are physicians trained and are cardiovascular causes overstated? Am J Med. 2004;117:492–8.CrossRefPubMed Lakkireddy DR, Gowda MS, Murray CW, Basarakodu KR, Vacek JL. Death certificate completion: how well are physicians trained and are cardiovascular causes overstated? Am J Med. 2004;117:492–8.CrossRefPubMed
Metadata
Title
Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates
Publication date
01-12-2015
Published in
BMC Musculoskeletal Disorders / Issue 1/2015
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-015-0727-7

Other articles of this Issue 1/2015

BMC Musculoskeletal Disorders 1/2015 Go to the issue